Meet the ‘who’ behind the ‘what’ we do at Beta Bionics

Our team

Meet the ‘who’ behind the ‘what’ we do.

At Beta Bionics, we’re a people-focused company here to serve the wider diabetes community.

As you’d expect, we’ve got incredible technical expertise and skills on our team to enable us to do that. But just as important, our people are a great bunch of human beings too. All committed and passionate in helping our community live fuller, more enjoyable lives.

Our leadership team

Our board of directors

Board observers

Amanda Black

Investment Analyst, Farallon Capital Management

Westley Dupray, CFA

Principal, Eventide Asset Management

Katie Hewitt

VP, and Chief Business Officer, Lilly New Ventures at Eli Lilly and Company

David Kendall, MD

Chief Medical Officer, Zealand Pharma

Finny Kuruvilla, MD, PhD

Co-Chief Investment Officer, Senior Portfolio Manager, Managing Director, Founding Member at Eventide Asset Management

Marie Lindegaard, MD, DMSc

Corporate Project Vice President for Diabetes, Clinical Drug Development, Novo Nordisk

Ken Lutchen

Dean of Engineering, Boston University

Michael Pratt

Managing Director, Technology Development at Boston University

Ready to GO BIONIC?

The iLet Bionic Pancreas automatically adjusts to your insulin needs so you don’t have to.